Smarter Studies
We work to deliver swifter and more effective translation of scientific research into patient benefits
Global Impact
We are at the forefront of resolving internationally important questions
Better Health
Our research helps to improve healthcare around the world
Latest News
A combination of two immunotherapy drugs benefits people with kidney cancer
Results from the RAMPART trial show that giving durvalumab and tremelimumab after surgery helps prevent kidney cancer coming back.
21 Oct
Weekly chemotherapy with bevacizumab improves ovarian cancer survival compared to having it once every three weeks
New results from the ICON8B trial were presented at the ESMO 2025 Conference.
20 Oct
Largest-ever Parkinson’s disease trial opens across UK
Using our multi-arm, multi-stage design, the EJS ACT-PD clinical trial aims to slow or stop the progression of Parkinsons’ disease.
16 Oct
Spotlight on our research at ESMO Congress 2025
We will present our latest cancer research from the RAMPART, ICON8B and STAMPEDE trials and STOPCAP meta-analysis at the 2025 ESMO Congress.
06 Oct
In 2024, we celebrated our 25th anniversary. That's 25 years of smarter studies, global impact and better health. '25 at 25' is a series of articles highlighting 25 of our major achievements in that time.
Research Themes
Cancer
Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types
Infections
Major international clinical trials answering questions of global public health significance
Neurodegenerative diseases
New generation of innovative multi-arm multi-stage trials to identify and test new therapeutic treatments in neurodegenerative diseases (NDD)
Methodology
Development of methods with direct impact on the design, conduct and analysis of studies
Other Research & Policy
This section will capture projects outside the current QQR themes
